ENvue Medical (FEED) EBITDA Margin (2014 - 2026)
ENvue Medical's (FEED) quarterly EBITDA Margin came in at 568.3% in Q1 2026, down 38762.0% year-on-year from N/an in Q1 2025, and up 88.03% on a QoQ basis from 4748.08% in Q4 2025.
ENvue Medical (FEED) EBITDA Margin (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has 13 years of EBITDA Margin data on file, last reported at 568.3% in Q1 2026.
- On a quarterly basis, EBITDA Margin fell 38762.0% year-over-year to 568.3% in Q1 2026; TTM through Mar 2026 was 1134.71%, a 95191.0% decrease from a year earlier, with the FY2025 full-year figure at 896.55%, down 75652.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 568.3%, up from 4748.08% in the prior quarter.
- Over the last five years, EBITDA Margin for FEED reached as high as 1674.51% in Q4 2022 and fell as low as 4748.08% in Q4 2025.
- Historically, EBITDA Margin has averaged 477.61% across 5 years, with a median of 298.02% in 2023.
- Across the five-year window, EBITDA Margin surged 199838 bps in 2022 and plunged 443952 bps in 2025, its largest moves.
- Year by year, EBITDA Margin stood at 1674.51% in 2022, then sank by 104 bps to 59.64% in 2023, then slumped by 417 bps to 308.56% in 2024, then plunged by 1439 bps to 4748.08% in 2025, then jumped by 88 bps to 568.3% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 568.3% in Q1 2026, 4748.08% in Q4 2025, and 311.22% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.17% |
| 10 | ENvue Medical | 1.18 Mn | -1.09 Mn | -55,000.00 | -568.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -568.30% |
| Dec 31, 2025 | -4,748.08% |
| Sep 30, 2025 | -311.22% |
| Jun 30, 2025 | -804.86% |
| Mar 31, 2025 | -180.68% |
| Dec 31, 2024 | -308.56% |
| Sep 30, 2024 | -257.98% |
| Jun 30, 2024 | -82.50% |
| Mar 31, 2024 | -61.67% |
| Dec 31, 2023 | -59.64% |
| Sep 30, 2023 | -146.29% |
| Jun 30, 2023 | -343.20% |
| Mar 31, 2023 | -298.02% |
| Dec 31, 2022 | 1,674.51% |
| Sep 30, 2022 | -952.58% |
| Jun 30, 2022 | -261.44% |
| Mar 31, 2022 | -408.82% |
| Dec 31, 2021 | -323.87% |
| Sep 30, 2021 | -173.95% |
| Jun 30, 2021 | -311.64% |